S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Tragedy that left 5 dead or missing puts spotlight on safety in Alaska charter fishing industry
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
NYSE:BAX

Baxter International (BAX) Stock Forecast, Price & News

$41.33
+0.10 (+0.24%)
(As of 06/2/2023 ET)
Compare
Today's Range
$40.82
$41.71
50-Day Range
$39.85
$47.68
52-Week Range
$37.35
$74.43
Volume
3.67 million shs
Average Volume
5.18 million shs
Market Capitalization
$20.91 billion
P/E Ratio
N/A
Dividend Yield
2.81%
Price Target
$52.38

Baxter International MarketRank™ Forecast

Analyst Rating
Hold
2.21 Rating Score
Upside/​Downside
26.7% Upside
$52.38 Price Target
Short Interest
Healthy
1.14% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-1.95
Upright™ Environmental Score
News Sentiment
0.03mentions of Baxter International in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$147,454 Sold Last Quarter
Proj. Earnings Growth
13.40%
From $2.91 to $3.30 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Medical Sector

58th out of 983 stocks

Surgical & Medical Instruments Industry

4th out of 97 stocks


BAX stock logo

About Baxter International (NYSE:BAX) Stock

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Receive BAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter.

BAX Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Baxter International (NYSE:BAX) Sees Large Volume Increase
Analyst Expectations for Baxter Intl's Future
We Called (ARWR) In Advance, Which Stocks Are Next?
Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.
Baxter International (NYSE:BAX) Now Covered by StockNews.com
Baxter International Inc. (NYSE:BAX) Short Interest Update
See More Headlines

BAX Price History

BAX Company Calendar

Ex-Dividend for 4/3 Dividend
2/23/2023
Dividend Payable
4/03/2023
Last Earnings
4/27/2023
Ex-Dividend for 7/3 Dividend
6/01/2023
Today
6/03/2023
Dividend Payable
7/03/2023
Next Earnings (Estimated)
7/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
07181310
Employees
60,000
Year Founded
1931

Price Target and Rating

Average Stock Price Forecast
$52.38
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+26.7%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
14 Analysts

Profitability

Net Income
$-2,433,000,000.00
Pretax Margin
-15.79%

Debt

Sales & Book Value

Annual Sales
$15.11 billion
Cash Flow
$12.60 per share
Book Value
$11.74 per share

Miscellaneous

Free Float
504,788,000
Market Cap
$20.91 billion
Optionable
Optionable
Beta
0.56

Social Links


Key Executives

  • Joe Almeida
    Chairman, President & Chief Executive Officer
  • James K. Saccaro
    Chief Financial Officer & Executive Vice President
  • Paulo Henrique Bolgar
    Vice President-Research & Development
  • Reaz Rasul
    EVP, President-Healthcare Systems & Technologies
  • Tobi Karchmer
    Chief Medical Officer & Senior Vice President













BAX Stock - Frequently Asked Questions

Should I buy or sell Baxter International stock right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BAX, but not buy additional shares or sell existing shares.
View BAX analyst ratings
or view top-rated stocks.

What is Baxter International's stock price forecast for 2023?

14 Wall Street analysts have issued 1 year target prices for Baxter International's shares. Their BAX share price forecasts range from $43.00 to $70.00. On average, they predict the company's share price to reach $52.38 in the next year. This suggests a possible upside of 26.7% from the stock's current price.
View analysts price targets for BAX
or view top-rated stocks among Wall Street analysts.

How have BAX shares performed in 2023?

Baxter International's stock was trading at $50.97 at the beginning of 2023. Since then, BAX shares have decreased by 18.9% and is now trading at $41.33.
View the best growth stocks for 2023 here
.

Are investors shorting Baxter International?

Baxter International saw a decline in short interest in May. As of May 15th, there was short interest totaling 5,710,000 shares, a decline of 5.5% from the April 30th total of 6,040,000 shares. Based on an average trading volume of 5,860,000 shares, the short-interest ratio is presently 1.0 days. Currently, 1.1% of the shares of the stock are sold short.
View Baxter International's Short Interest
.

When is Baxter International's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our BAX earnings forecast
.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) announced its quarterly earnings data on Thursday, April, 27th. The medical instruments supplier reported $0.59 EPS for the quarter, topping the consensus estimate of $0.48 by $0.11. The medical instruments supplier had revenue of $3.65 billion for the quarter, compared to the consensus estimate of $3.60 billion. Baxter International had a negative net margin of 16.34% and a positive trailing twelve-month return on equity of 24.29%. The firm's revenue was down 1.6% on a year-over-year basis. During the same period last year, the company earned $0.93 EPS.
Read the conference call transcript
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Monday, May 1st. Investors of record on Friday, June 2nd will be given a dividend of $0.29 per share on Monday, July 3rd. This represents a $1.16 dividend on an annualized basis and a yield of 2.81%. The ex-dividend date is Thursday, June 1st.
Read our dividend analysis for BAX
.

Is Baxter International a good dividend stock?

Baxter International (NYSE:BAX) pays an annual dividend of $1.16 per share and currently has a dividend yield of 2.81%.
Read our dividend analysis for BAX.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International issued an update on its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $0.59-$0.61 for the period, compared to the consensus EPS estimate of $0.60. The company issued revenue guidance of $3.78 billion-$3.82 billion, compared to the consensus revenue estimate of $3.77 billion.

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International Chief Executive Officer José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Intel (INTC), Abbott Laboratories (ABT), Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.77%), Ameriprise Financial Inc. (1.03%), Bank of New York Mellon Corp (0.78%), Cooke & Bieler LP (0.64%), Coho Partners Ltd. (0.40%) and Sumitomo Mitsui Trust Holdings Inc. (0.28%). Insiders that own company stock include Albert P L Stroucken, Andrew Frye, Brian Stevens, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason and John D Forsyth.
View institutional ownership trends
.

How do I buy shares of Baxter International?

Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $41.33.

How much money does Baxter International make?

Baxter International (NYSE:BAX) has a market capitalization of $20.91 billion and generates $15.11 billion in revenue each year. The medical instruments supplier earns $-2,433,000,000.00 in net income (profit) each year or ($4.88) on an earnings per share basis.

How many employees does Baxter International have?

The company employs 60,000 workers across the globe.

Does Baxter International have any subsidiaries?
The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..
Read More
How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The official website for the company is www.baxter.com. The medical instruments supplier can be reached via phone at (224) 948-2000, via email at global_corp_investor_relations@baxter.com, or via fax at 224-948-1813.

This page (NYSE:BAX) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -